Polyphenols From Nonalcoholic Red Wine and Healthy Aging: an Opportunity to Understand Diet Modulation of the Aging Process From a Multidimensional Perspective
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 72
- 试验地点
- 3
- 主要终点
- Cognitive function
研究概览
简要总结
Polyphenols, precisely resveratrol, with red wine as the most substantial source, was associated with improvements in cognitive function. Also, the loss of muscle mass and strength in elderly, that significantly increases dependency of these people, it could be attributed to alterations in gut microbiota through the "gut-muscle axis" and this underline the urgent need to efficiently find out any intervention or preventive approach via modulation of gut microbiota to improve muscle function in elderly. In this context, red wine polyphenols exert their effects through interaction with gut microbiota following the well-known two-way interaction between polyphenols and gut microbiota by promoting the proliferation of beneficial bacteria and increasing their abundance. Similarly, aging cognitive decline can be modulate by microbiota, notably through "gut-brain axis". Additionally, dietary polyphenols can delay inflammation or/and oxidation on the onset of age-related cognitive decline or muscular oxidation or cardiovascular factors risk factors, all of them relevant factors for the onset of physical frailty and dependence in elderly.
Moreover, wine is a singular alcoholic beverage with a high content of phenolic compounds of a very diverse nature on which numerous protective effects on health have been described. In fact, wine, in addition to alcohol, contains a complex mixture of polyphenols, including anthocyanins and non-coloured phenols as proanthocyanidins, flavonols, hydroxycinnamic and hydroxybenzoic acids, stilbenes and lignans. Thus, the bioprotective effects of wine polyphenols could be the consequence of the synergistic effect of this complex mixture of polyphenols from the grape and the winemaking process. That is why it is essential to clarify whether consumption of polyphenols from red wine provided by a nonalcohol red wine within a healthy diet can produce beneficial effects on health, differentiating this pattern from a general consumption of alcohol generally associated with negative effects. Based on the ethical limitations to carry out diet intervention studies with wine in humans, this project proposes the use of a nonalcoholic wine as vehicle of the complex mixture of red wine polyphenols.
The hypothesis of our research is that regular consumption of red wine polyphenols, 150 mg/day, delivered through a nonalcoholic red wine, in the context of a Mediterranean diet (MD pattern), could promote protective mechanisms for a healthy aging, especially through its beneficial effects on cognitive and locomotor abilities and mediated by the modulation of the intestinal microbiota (composition, function and associated metabolome). The main objective of the WinAging project is to add knowledge concerning the diet modulation of molecular mechanisms of the aging process through multi-omic approaches based on the potential health effects of a dietary strategy by a sustained MD supplementation with nonalcoholic red wine rich in polyphenols to tackle cognitive and locomotor abilities in early elderly home-dwelling subjects.
The specific objectives:
-
Objective 1. To develop a nonalcoholic red wine with high phenolic content and sensorial acceptability.
-
Objective 2. To evaluate the chronic effects of the intake of wine polyphenols (average dose 150 mg/day) delivered through a nonalcoholic red wine in the context of a MD in early elderly home-dwelling subjects, and applying participatory research to increase adherence of subjects in the clinical intervention study.
-
Objective 2.1. To identify selective biological phenolic metabolites in human urine samples to be used as biomarkers of nonalcoholic red wine intake.
-
Objective 2.2. To assess the effects of the diet supplementation with red wine polyphenols on the improvement of cognitive ability.
-
Objective 2.3. To assess the effects of the diet supplementation with red wine polyphenols on the improvement of locomotor ability
-
Objective 2.4. To evaluate the effect of the diet supplementation with red wine polyphenols on the improvement of cardiovascular disease (CVD) risk factors.
-
Objective 3. To unravel the underlying mechanisms involved in the potential beneficial effects of red wine polyphenols on aging.
-
Objective 3.1. To evaluate the influence on microbiota composition, function and microbial catabolites.
-
Objective 3.2. To evaluate the impact on inflammation and gut health.
-
Objective 3.3. To evaluate the impact on metabolic pathways related with aging
-
Objective 3.4. To analyze the impact on age-related epigenetic modifications
-
Objective 3.5. To deeply characterize the underlying muscle signalling pathways affected using an animal model of aging.
-
Objective 4. To apply integrative computational analyses for the identification of variables (clinical or gut-related) more determinant for a successful prevention of locomotor and cognitive abilities associated with wine polyphenols.
详细描述
A total of 72 home-dwelling early elderly volunteers (men and women) 60-74 years old will be included in the intervention (36 in each arm of the intervention).
During the study there will be 11 visits in total. Visits will be every 4 weeks form the V1. The study visits will be the following:
-
Screening visit (V0).
-
Basal visit (V1).
-
Visits during intervention (V2, V3, V4, V5, V6, V7, V8, V9).
-
3-month study visit (V4)
-
6-month study visit (V7)
-
Telephone visits (V2, V3, V5, V6, V8, V9)
-
Final study visit (V10). In visits V0, V1, V4, V7 and V10 volunteers must present themselves in fasting conditions of 8 hours to obtain fasting blood samples.
-
In addition, future candidates will be provided with the nonalcoholic wine, selected for study and allowed to taste it for one week to check its tolerability and sensory acceptance and thus ensure that candidates can commit to drinking the study wine daily for 9 months and reduce follow-up losses during the intervention.
Basal visit (V1; week 0):
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 60 Years 至 74 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •1. Men or women between 60-74 years old; Sensory tolerance to red wine; Written informed consent provided before the initial screening visit.
排除标准
- •Men or women >75 years old,
- •Hypoglucaemiant treatment or type 1 and type 2 diabetes mellitus diagnosed
- •Anaemia (hemoglobin ≤13 g/dL in men and ≤12 g/dL in women)
- •Subjects diagnosed of intestinal disorders such as chron disease, colitis ulcerous, and irritable bowel syndrome
- •To present a clinical active chronic disease
- •To present severe sarcopenia
- •To present cognitive impairment (MMSE ≤ 24 or clinical diagnosis of mild cognitive impairment or dementia)
- •Dietary allergies to: Mediterranean foods (eg, nuts), sulphytes or nitrates
- •Use of antioxidants supplements
- •Regular consumers of red wine who do not agree to change the consumption of red wine with alcohol to nonalcholized wine during the intervention
- •Chronic alcoholism
- •Current or past participation in a clinical trial or consumption of a research product in the 30 days prior to inclusion in the study
- •Failure to follow the study guidelines. For participation in the muscle biopsy, additional exclusion criteria included: Use of prescription anti-platelet medication; Prescription anticoagulant use (or antiaggregant, or acenocoumarol; Conditions which would reduce healing; or known allergy to lidocaine.
研究组 & 干预措施
Nonalcoholic red wine group (Intervention group)
Mediteranean diet + nonalcoholic red wine
干预措施: Nonalcoholic red wine group (Intervention group) (Dietary Supplement)
Drinking water group (Control group)
Mediterranean diet + drinking water
干预措施: Drinking water group (Control group) (Dietary Supplement)
结局指标
主要结局
Cognitive function
时间窗: Visit 0 (week -1), visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36)
The MMSE test for cognitive function. The total test score ranges from 0 (impaired) to 30 (normal) (Beaman et al., 2004).
Muscle strength
时间窗: Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36)
The muscle strength based on handgrip dynamometry (Jamar dynamometer; Sammons Preston Rolyan, Bolingbrook, IL)
次要结局
- Physical activity compliance(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Sedentary habits(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Sleep quality(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Life quality(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Depressive symptoms(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Nutritional intake(Visit 1 (week 0), visit 2 (week 4), visit 3 (week 8), visit 4 (week 12), visit 5 (week 16), visit 6 (week 20), visit 7 (week 24), visit 8 (week 28), visit 9 (week 32), visit 10 (week 36)))
- Brain volume(Visit 1 (week 0), visit 10 (week 36))
- Cognitive ability assessment(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Skeletal muscle strength(Visit 1 (week 0), visit 10 (week 36))
- Physical performance(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Biological age marker (Aging biomarker)(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Signalling pathways in skeletal muscle(Visit 1 (week 0), visit 10 (week 36))
- Stress Response and Mitochondria(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Vascular parameters(Visit 0, visit 1Visit 0 (week -1), visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36), visit 4, visit 7, visit 10)
- Faecal microbial composition(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Faecal microbial function(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Faecal metabolome(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- DNA methylation(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Gut permeability determined on plasma(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Biomarkers of wine intake compliance(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Anthropometric measures(Visit 0 (week -1), visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Nutritional status(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Cognitive function(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Muscle mass, wasting and turnover(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Glucose homeostasis(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Lipid profile(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Oxidative markers(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Inflammation markers(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Biomarkers of endothelial dysfunction(Visit 1 (week 0), visit 7 (week 24), visit 10 (week 36))
- Nutritional intake(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
- Nutritional status(Visit 0 (week -1))
- Muscle mass, wasting and turnover(Visit 1 (week 0), visit 4 (week 12), visit 7 (week 24), visit 10 (week 36))
研究者
Rosa Sola
Full Professor, Dr. Rosa Solà Alberich
University Rovira i Virgili
